Yahoo Web Search

Search results

1. • Sarepta Jumps After Rival Gene Therapy From Pfizer Flops

     Investor's Business Daily· 5 days ago

     The news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...

2. • Raleigh Capital Management Inc. Sells 2,270 Shares of Pfizer Inc. (NYSE:PFE)

     ETF DAILY NEWS· 2 days ago

     The firm owned 64,481 shares of the biopharmaceutical company’s stock after selling 2,270 shares during the quarter. Raleigh Capital Management Inc.’s holdings in

3. • Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? - BioNTech (NASDAQ:BNTX)

     Benzinga· 21 hours ago

     Also Read: What’s Going With BioNTech Stock On Monday? The partial hold affects the enrollment of new patients in the trial in the U.S., BioNTech said in an SEC filing.

4. • Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)

     ETF DAILY NEWS· 3 days ago

     The fund bought 2,998 shares of the biopharmaceutical company’s stock, valued at approximately $86,000. Taylor Financial Group Inc. bought a new stake in Pfizer< ...

5. • 

     3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade

     Motley Fool via Yahoo Finance· 3 days ago

     Pfizer reported first-quarter sales that rose 11% year over year if we exclude Comirnaty and...

6. • Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC

     ETF DAILY NEWS· 6 days ago

     The firm owned 479,858 shares of the biopharmaceutical company’s stock after selling 74,822 shares during the period. Cresset Asset Management LLC’s holdings in Pfizer ...

7. • Gateway - Quartz

     Quartz· 10 hours ago

     Moderna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...

8. • Pfizer's gene-therapy trial failure boosts Sarepta's stock

     Morningstar· 5 days ago

     Shares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial. Pfizer Inc. said ...

9. • Studio Investment Management LLC Buys 2,236 Shares of Pfizer Inc. (NYSE:PFE)

     ETF DAILY NEWS· 4 days ago

     (NYSE:PFE – Free Report) by 2.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 109,640 shares of the biopharmaceutical company’s < ...

10. • 

      Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal

      Zacks via Yahoo Finance· 5 days ago

      Pfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...